查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1362891

临床试验配对软体市场规模、份额、趋势分析报告：按部署模式、最终用途、地区和细分市场预测，2023-2030 年

Clinical Trials Matching Software Market Size, Share & Trends Analysis Report By Deployment Mode (Web & Cloud-based, On-premise), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

临床试验匹配软体市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，到 2030 年，全球临床试验配对软体市场规模预计将达到 3.961 亿美元。

预计2023年至2030年年复合成长率为13.2%。正在进行的临床试验数量的大幅增加预计将推动市场发展。此外，越来越多地采用临床试验配对软体进行临床试验，以及医疗保健领域对虚拟测试和自动化的需求不断增加，也是促进市场成长的关键要素之一。配对软体有助于透过以患者为中心的方法进行有效、快速的患者配对。

在临床试验中，招募和配对患者可能非常耗时，而且找到合适的配对对像也很困难。筛选和搜寻合格的潜在受访者、考虑临床实验的各个方面、建立意识并获得参与的知情同意是患者招募过程中考虑的因素。根据资格要求招募人员至关重要，因此试验配对技术已被证明是有用的，特别是在 COVID-19 情况下。

该软体不仅可以帮助找到合适的匹配，还可以节省研发相关成本，并在无需人工干预的情况下实现平稳操作。软体供应商正在引入新的创新技术来巩固其市场地位。例如，2022 年 2 月，CTMA 扩大了 CT-SCOUT 技术在风湿病领域的应用。

临床试验配对软体市场的报告亮点：

  • 根据部署模式，基于网路和云端基础市场预计将在 2022 年以收益主导市场，并在预测期内实现最快的年复合成长率。云端运算模式不需要维护或保养，客户只需为他们使用的服务付费。另一方面，本地部署需要内部基础架构、内部 IT 支援、营运资金和高整合成本。因此，云端基础的模型是首选。
  • 按最终用途划分，製药和生物技术公司在 2022 年获得了最大的收益占有率，因为在正在进行的临床研究中越来越多地采用软体来降低研发活动的成本。
  • CRO 最终用途领域预计在预测期内将以 13.7% 的年复合成长率增长最快。 CRO 可以快速提供临床试验所需的专业支援、专业知识和实施经验，而无需申办者聘请全职人员。 CRO 服务是首选的外包目的地，因为它们具有成本效益和时间效益。
  • 2022 年，随着製药、生物技术和医疗保健相关企业越来越多地采用临床试验匹配软体，北美在企业收益方面领先市场。
  • 由于有大量患者群支援轻鬆招募患者/候选人，预计亚太地区将在预测期内实现最快的成长率。

目录

第1章调查方法与范围

第2章执行摘要

第3章临床试验配对软体市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 临床试验配对软体市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章临床试验匹配软体：部署模式估算与估算/趋势分析

  • 临床试验配对软体市场：重点
  • 临床试验匹配软体市场：2022 年和 2030 年趋势和市场占有率分析
  • 云端基础
    • 2018 年至 2030 年网路和云端基础的市场估计和预测
  • 本地
    • 2018 年至 2030 年本地市场估计与预测

第5章临床试验配对软体：最终用途估算与趋势分析

  • 临床试验配对软体市场：重点
  • 临床试验匹配软体市场：2022 年和 2030 年趋势和市场占有率分析
  • 製药和生物技术公司
  • CRO
  • 医疗设备公司

第6章临床试验配对软体市场：区域估计与趋势分析

  • 区域预测
  • 按地区分類的临床试验匹配软体市场：市场要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • IBM Clinical Development
    • Antidote Technologies, INC.
    • Ofni Systems
    • Sss International Clinical Research
    • Clario
    • Advarra
    • Aris Global
    • Bsi Business Systems Integration Ag
    • Teckro
    • Clinical Trials Mobile Application
Product Code: GVR-4-68039-921-8

Clinical Trials Matching Software Market Growth & Trends:

The global clinical trials matching software market size is expected to reach USD 396.1 million by 2030, based on a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 13.2% from 2023 to 2030. The significant increase in the number of ongoing clinical trials is likely to drive the market. In addition, the growing adoption of the clinical trial matching software catering to the clinical trials, along with the increased demand for virtual trials and automation in the healthcare sector are some of the key factors contributing to the market growth. The matching software help in effective and fast patient matching with patient-centric approaches.

In clinical trials, patient recruitment or matching can be time-consuming, and finding the right match can be a hurdle. Screening or locating prospective respondents who are qualified, considering all elements of the trials, verifying awareness, and getting informed consent to participate are the factors taken into consideration while recruiting patients. Enlisting the individuals in accordance with the qualifying requirements is crucial, hence the trial matching technology has been proved to be useful, especially in the COVID-19 scenario.

The software helps not only to find the right match but also saves the R&D-related costs, enabling smoother operations without human intervention. The software providers are introducing new innovative techniques to strengthen their market position. For instance, in February 2022, the CTMA expanded CT-SCOUT technology offering in rheumatology.

Clinical Trials Matching Software Market Report Highlights:

  • Based on deployment mode, the web and cloud based segment dominated the market in terms of revenue in 2022 and it is expected to register the fastest CAGR during the forecast period. The cloud computing models operate with no maintenance or upkeep charges and customers only have to pay for the services that are used. On the other hand, on-premises deployment involves in-house infrastructure, in-house IT support, working capital, and higher integration costs. Hence, web and cloud based models are preferred
  • Based on end use, pharmaceuticals and biotechnology companies captured the largest revenue share in 2022 owing to the higher adoption of software during ongoing clinical studies for cost-saving in the R&D activities
  • The CROs end-use segment is anticipated to expand at the fastest CAGR of 13.7% during the forecast period. CROs provide the professional assistance, expertise, and execution experience required for clinical trials quickly, without the need for the sponsor to engage such people full-time. CROs are preferred for outsourcing as their services are cost and time-effective
  • In 2022, North America led the market in terms of revenue owing to the rising adoption of the clinical trial matching software by the pharma, biotech, and medical companies in the region
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period due to the availability of a large patient pool supporting easy recruitment of patients/candidates

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Deployment Mode
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Deployment mode outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Clinical Trials Matching Software Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Clinical Trials Matching Software Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Clinical Trials Matching Software: Deployment Mode Estimates & Trend Analysis

  • 4.1. Clinical Trials Matching Software Market: Key Takeaways
  • 4.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Web & Cloud-based
    • 4.3.1. Web & Cloud-Based market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. On-premises
    • 4.4.1. On-premises market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Clinical Trials Matching Software: End-use Estimates & Trend Analysis

  • 5.1. Clinical Trials Matching Software Market: Key Takeaways
  • 5.2. Clinical Trials Matching Software Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmaceutical & Biotechnology Companies
    • 5.3.1. Pharmaceutical & Biotechnology Companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. CROs
    • 5.4.1. CROs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Medical Device Firms
    • 5.5.1. Medical Device Firms market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Clinical Trials Matching Software Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Clinical Trials Matching Software Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. IBM Clinical Development
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Antidote Technologies, INC.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Ofni Systems
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Sss International Clinical Research
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Clario
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Advarra
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Aris Global
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Bsi Business Systems Integration Ag
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Teckro
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Clinical Trials Mobile Application
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 3 North America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 6 U.S. clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 8 Canada clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 10 Europe clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 13 Germany clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 15 UK clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 17 France clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 19 Italy clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 21 Spain clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Sweden clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 23 Sweden clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Norway clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 25 Norway clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Denmark clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 27 Denmark clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 31 China clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 32 China clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 34 Japan clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 36 India clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
  • Table 37 Australia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 38 Australia clinical trials matching software market, by end-use, (USD Million) 2018 - 2030
  • Table 39 Thailand clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 40 Thailand clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 42 South Korea clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 44 Latin America clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 47 Brazil clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 49 Mexico clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 51 Argentina clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa clinical trials matching software market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 56 South Africa clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 60 UAE clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait clinical trials matching software market, by deployment mode, 2018 - 2030 (USD Million)
  • Table 62 Kuwait clinical trials matching software market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Clinical trials matching software: Market outlook
  • Fig. 9 Clinical trials matching software: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Clinical trials matching software market driver impact
  • Fig. 15 Clinical trials matching software market restraint impact
  • Fig. 16 Clinical trials matching software market strategic initiatives analysis
  • Fig. 17 Clinical trials matching software market: Deployment mode movement analysis
  • Fig. 18 Clinical trials matching software market: Deployment mode outlook and key takeaways
  • Fig. 19 Web & cloud-based market estimates and forecasts, 2018 - 2030
  • Fig. 20 On-premises market estimates and forecasts, 2018 - 2030
  • Fig. 21 Clinical trials matching software market: End-use movement analysis
  • Fig. 22 Clinical trials matching software market: End-use outlook and key takeaways
  • Fig. 23 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 24 CROs market estimates and forecasts, 2018 - 2030
  • Fig. 25 Medical devices firms market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global clinical trials matching software market: Regional movement analysis
  • Fig. 27 Global clinical trials matching software market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030